ERBB2 and neoplasm: According to the findings of this study, the two monomeric CAR-Ts demonstrated target antigen-dependent effector cell activation and expansion, cytokine production, and tumor cell lysis upon co-cultivation with Jurkat cells genetically engineered to express CD20 or HER2 or both on their surface [112].